Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01978314 · ClinicalTrials.gov registry record · NA
FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.
A NA study of Chronic Kidney Disease and Acute Kidney Injury, sponsored by FAST BioMedical.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT01978314 is a NA study of Chronic Kidney Disease and Acute Kidney Injury that has completed, run by FAST BioMedical. The registered enrollment target is 33 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01978314, a NA study of Chronic Kidney Disease and Acute Kidney Injury, has completed, sponsored by FAST BioMedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single site study designed to evaluate the FAST mGFR Test™ in healthy adult volunteers, patients with varying degrees of chronic kidney disease (CKD), and patients with acute kidney injury (AKI).
Conditions Studied
Interventions
- DEVICE 75 mg / 6 mL VFI™
Study Locations (1)
Alabama
- University of Alabama Birmingham, Division of Nephrology - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01978314
The ClinicalTrials.gov registry entry for NCT01978314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (99% lower). The listed sponsor is FAST BioMedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which 75 mg / 6 mL VFI™ is the first listed.
NCT01978314 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT01978314 about?
NCT01978314 is a clinical study titled "FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.". This is a single site study designed to evaluate the FAST mGFR Test™ in healthy adult volunteers, patients with varying degrees of chronic kidney disease (CKD), and patients with acute kidney injury (AKI).
What is the current status of trial NCT01978314?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2013-08. Estimated completion is 2014-08.
What conditions does trial NCT01978314 study?
This clinical trial studies the following conditions: Chronic Kidney Disease, Acute Kidney Injury.
What interventions are being tested in trial NCT01978314?
The interventions under investigation include: 75 mg / 6 mL VFI™ (DEVICE).
Who is sponsoring clinical trial NCT01978314?
This trial is sponsored by FAST BioMedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01978314 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
-
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
RECRUITING · NA
-
Transforming Hemodialysis-Related Vascular Access Education
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.